STCUBE
Develops immuno-oncology therapies targeting novel immune checkpoints for cancer.
052020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7052020005
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 영동대로 511 2201(삼성동, 무역센터 트레이드타워), 강남구
- Website:
- https://www.stcube.com/en/
Description
STCube is a biopharmaceutical company specializing in the research and development of innovative immuno-oncology therapies. The company focuses on discovering treatments that target novel immune checkpoints to overcome cancer's immune evasion mechanisms. Its primary area of research involves BTN1A1, a novel immune checkpoint target often expressed in a mutually exclusive manner with PD-L1. STCube's lead drug candidate, Nelmastobart, is a first-in-class anti-BTN1A1 immune checkpoint inhibitor. This therapy is being developed to provide a new treatment option for patients with treatment-resistant, refractory, or recurrent cancers that have limited therapeutic alternatives. The company utilizes a precision-medicine, biomarker-driven approach in its clinical development programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-22 00:00 |
권리락 (유상증자)
|
Korean | 3.5 KB | ||
| 2024-09-27 00:00 |
투자설명서
|
Korean | 2.7 MB | ||
| 2024-09-26 00:00 |
[기재정정]증권신고서(지분증권) (2024.11)
|
Korean | 3.4 MB | ||
| 2024-09-09 00:00 |
[기재정정]증권신고서(지분증권) (2024.11)
|
Korean | 3.6 MB | ||
| 2024-09-04 00:00 |
투자판단관련주요경영사항(임상시험결과) (면역항암제 hSTC810 의 다국가 임상 1상 시험 결과)
|
Korean | 15.2 KB | ||
| 2024-08-27 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 37.6 KB | ||
| 2024-08-26 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 29.9 KB | ||
| 2024-08-26 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 35.5 KB | ||
| 2024-08-26 00:00 |
증권신고서(지분증권) (2024.11)
|
Korean | 2.5 MB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.2 MB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.2 MB | ||
| 2024-03-28 00:00 |
정기주주총회결과
|
Korean | 19.4 KB | ||
| 2024-03-20 00:00 |
주권매매거래정지 (관리종목지정사유발생)
|
Korean | 4.7 KB | ||
| 2024-03-20 00:00 |
감사보고서제출
|
Korean | 25.9 KB | ||
| 2024-03-20 00:00 |
사업보고서 (2023.12)
|
Korean | 450.4 KB |
Automate Your Workflow. Get a real-time feed of all STCUBE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STCUBE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STCUBE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
